BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Clinical trials for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
PET scans guide new combo therapy for recurrent prostate cancer in major trial
Disease control Recruiting nowThis Phase III trial is testing whether adding a drug called apalutamide (with or without targeted radiation) to standard care can better control prostate cancer that has come back after surgery. The study uses PET scans to see if the cancer has spread outside the pelvis, and the…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 23, 2026 23:36 UTC
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation method (SBRT) works as well as a slightly longer radiation approach (hypofractionated radiotherapy) for men whose prostate cancer has come back or spread to a few spots after surgery. About 118 participants will receive o…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
New trial aims to Fine-Tune prostate cancer treatment timing
Disease control Recruiting nowThis study looks at the best timing for combining targeted radiation (SBRT) with hormone therapy in men whose prostate cancer has returned and spread. It also tests if radiation to the pelvis can stop cancer from spreading further. About 532 men with recurrent, hormone-sensitive …
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Home cancer care trial aims to ease burden for black men with prostate cancer
Symptom relief Recruiting nowThis study looks at whether giving cancer therapy at home instead of in a clinic is safe and improves the experience for Black men with advanced prostate cancer. About 38 participants will receive treatment both at home and in the clinic, then rate their satisfaction and report s…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 16, 2026 12:54 UTC